Serum concentrations of risperidone and 9‐OH risperidone following intramuscular injection of long‐acting risperidone compared with oral risperidone medication
Authors:
- 7 June 2006
- journal article
- research article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 114 (1) , 21-26
Abstract
Objective: To compare serum concentrations of risperidone, 9‐hydroxy (OH) risperidone and risperidone plus 9‐OH risperidone, as well as the 9‐OH risperidone/risperidone ratio in patients receiving depot and oral risperidone.Method: Serum concentrations from 78 patients receiving three different doses of risperidone depot were measured and compared with serum concentrations from 82 patients taking three different doses of oral risperidone.Results: Patients receiving risperidone depot had significantly lower serum concentrations of risperidone plus 9‐OH risperidone than patients taking oral risperidone. More interestingly, the 9‐OH risperidone/risperidone ratio was also significantly lower in patients receiving risperidone depot than in patients taking oral risperidone.Conclusion: Serum concentrations of risperidone plus 9‐OH risperidone may be a rather poor indication of the antipsychotic efficacy of risperidone unless their ratio is also considered.Keywords
This publication has 33 references indexed in Scilit:
- Therapeutic drug monitoring of patients on risperidone depotNordic Journal of Psychiatry, 2005
- Serum Concentrations of Risperidone and 9-Hydroxyrisperidone After Administration of the Long-Acting Injectable Form of RisperidoneTherapeutic Drug Monitoring, 2005
- Clinical review of a long-acting, injectable formulation of risperidoneClinical Therapeutics, 2004
- Early Clinical Experience With Risperidone Long-Acting InjectionThe Journal of Clinical Psychiatry, 2004
- Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidoneEuropean Psychiatry, 2004
- Depot risperidone for schizophrenia2003
- A Pilot Study on Risperidone MetabolismThe Journal of Clinical Psychiatry, 1999
- Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta™) in patients with schizophreniaInternational Journal of Neuropsychopharmacology, 1999
- The Relationship Between Serum Concentration and Therapeutic Effect of Haloperidol in Patients with Acute SchizophreniaClinical Pharmacokinetics, 1998
- Clinical Pharmacokinetics of the Depot AntipsychoticsClinical Pharmacokinetics, 1985